Overview
- 54 inspections across 48 sites are on record.
- 210 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2014-07-10.
At a glance
Inspections
54
Sites
48
Observations
210
Career since
Aug 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Cubist Pharmaceuticals, Inc. | 10 Jul 2014 | Human Drugs | On file |
| Charles River Laboratories, Inc. | 12 Jun 2014 | Human Drugs | On file |
| Covis Pharma GmBH | 21 May 2014 | Human Drugs | On file |
| N-Molecular, Inc. dba SOFIE | 11 Dec 2013 | Human Drugs | On file |
| Lonza Biologics, Inc. | 30 Sep 2013 | Human Drugs | On file |
Sites inspected
Cubist Pharmaceuticals, Inc.Lexington, United States1 insp.
Charles River Laboratories, Inc.Wilmington, United States1 insp.
Covis Pharma GmBHWaltham, United States1 insp.
N-Molecular, Inc. dba SOFIEHaverhill, United States1 insp.
Lonza Biologics, Inc.Portsmouth, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Rory Geyer9 shared
Megan A Haggerty8 shared
Stacey S Degarmo5 shared
Philip Kreiter5 shared
Mary-Jeanet Mcgarry3 shared
Amy C Jordan3 shared
Justine M Corson3 shared
Margaret E Walsh3 shared
Maya M Davis2 shared
Debra M Emerson2 shared
Full investigator report
Get the verbatim findings behind Ramon E Martinez's 210 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site